 Insulinoma
"Insulinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
| Descriptor ID |
D007340
|
| MeSH Number(s) |
C04.557.470.035.100.852 C04.588.274.761.249.500 C04.588.322.475.249.500 C06.301.761.249.500 C06.689.667.249.500 C19.344.421.249.500
|
| Concept/Terms |
Insulinoma- Insulinoma
- Insulinomas
- Adenoma, beta-Cell
- Adenoma, beta Cell
- Adenomas, beta-Cell
- beta-Cell Adenoma
- beta-Cell Adenomas
- Insuloma
- Insulomas
- beta-Cell Tumor
- Tumor, beta-Cell
- Tumors, beta-Cell
- beta Cell Tumor
- beta-Cell Tumors
|
Below are MeSH descriptors whose meaning is more general than "Insulinoma".
Below are MeSH descriptors whose meaning is more specific than "Insulinoma".
This graph shows the total number of publications written about "Insulinoma" by people in this website by year, and whether "Insulinoma" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1997 | 1 | 1 | 2 | | 1999 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2009 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2012 | 0 | 2 | 2 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulinoma" by people in Profiles.
-
Harvey KE, Tang S, LaVigne EK, Pratt EPS, Hockerman GH. RyR2 regulates store-operated Ca2+ entry, phospholipase C activity, and electrical excitability in the insulinoma cell line INS-1. PLoS One. 2023; 18(5):e0285316.
-
Harvey KE, LaVigne EK, Dar MS, Salyer AE, Pratt EPS, Sample PA, Aryal UK, Gowher H, Hockerman GH. RyR2/IRBIT regulates insulin gene transcript, insulin content, and secretion in the insulinoma cell line INS-1. Sci Rep. 2022 05 11; 12(1):7713.
-
Wright CJ, McKenna S, De Dios R, Boehmer BH, Nguyen L, Ghosh S, Sandoval J, Rozance PJ. Lower threshold to NF?B activity sensitizes murine ?-cells to streptozotocin. J Endocrinol. 2021 05 06; 249(3):163-175.
-
Farahmand A, Kerr JM, Lawler HM. MAXIMIZING THE UTILITY OF THE 72-HOUR FAST IN EVALUATING HYPOGLYCEMIA. Endocr Pract. 2021 Jan; 27(1):80-81.
-
Varela D, Yu A, Saxon D. Insulinoma Masquerading as Transient Neurocognitive Impairment. Am J Med. 2018 09; 131(9):e377-e379.
-
Abedini A, Cao P, Plesner A, Zhang J, He M, Derk J, Patil SA, Rosario R, Lonier J, Song F, Koh H, Li H, Raleigh DP, Schmidt AM. RAGE binds preamyloid IAPP intermediates and mediates pancreatic ? cell proteotoxicity. J Clin Invest. 2018 02 01; 128(2):682-698.
-
Fudge DH, Black R, Qin Y. Optical Recording of Cellular Zinc Dynamics with Zinc-Finger-Based Biosensors. Methods Mol Biol. 2018; 1867:103-112.
-
Beisang D, Forlenza GP, Luquette M, Sarafoglou K. Sporadic Insulinoma Presenting as Early Morning Night Terrors. Pediatrics. 2017 Jun; 139(6).
-
Jaiswal DD, Wallace EA. Surgery versus snacking as treatment of insulinoma. Mayo Clin Proc. 2014 Jan; 89(1):e7-8.
-
Wu Z, Liu S, Hassink M, Nair I, Park R, Li L, Todorov I, Fox JM, Li Z, Shively JE, Conti PS, Kandeel F. Development and evaluation of 18F-TTCO-Cys40-Exendin-4: a PET probe for imaging transplanted islets. J Nucl Med. 2013 Feb; 54(2):244-51.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|